Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
Antineoplastic Combined Chemotherapy Protocols
Leukemia, Lymphocytic, Chronic, B-Cell
Sequential therapy with F-->C-->R yields improvement in quality of response, with many patients achieving a PCR-negative state.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency